New Cell Therapy Brings Hope to 300M With Cornea Disease

A California biotech company just launched a groundbreaking program to create lab-grown corneal cells that could help 300 million people worldwide facing blindness from a degenerative eye disease.

The treatment could solve a devastating shortage where only one donor cornea exists for every 70 patients who need one.